Investor: Company Misled Investors About Ability To Purchase COVID-19 Test Kits

(May 1, 2020, 2:05 PM EDT) -- NEW YORK — A provider of data content and services to health care providers and its CEO misled investors by stating that the company was in the process of receiving millions of rapid testing kits for the novel coronavirus with the ability to obtain millions more over a 23-week period, a shareholder alleges in an April 29 securities class action complaint filed in New York federal court (Daniel Yannes v. SCWorx Corp., et al., No. 20-3349, S.D. N.Y.)....

Attached Documents

Related Sections